financetom
Business
financetom
/
Business
/
Air Products lowers full-year profit forecast, shares fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Air Products lowers full-year profit forecast, shares fall
May 25, 2025 11:09 PM

(Reuters) -Air Products cut its annual profit forecast on Thursday and the industrial gas maker reported lower-than-expected quarterly earnings, hurt by lower sales volumes and higher costs, sending the company's shares down 4% premarket.

U.S. manufacturing activity contracted in March after growing for two months straight as President Donald Trump's wave of tariffs eroded business and consumer confidence, impacting demand for Air Products' gases and related services.

The company said volumes were squeezed due to weak global helium demand and the divestiture of its LNG process technology and equipment business.

Air Products, which makes a range of industrial gases including hydrogen, helium and nitrogen, now expects annual adjusted earnings to be between $11.85 and $12.15 per share. Prior expectation was a range of $12.70 to $13.00 per share.

It also forecast third-quarter adjusted profit between $2.90 and $3.00 per share, falling short of the average analyst estimate of $3.28, according to data compiled by LSEG.

The dour results and forecast come after Air Products lost the proxy fight against activist investor Mantle Ridge, which had been pushing the company to replace its 80-year-old CEO.

On an adjusted basis, the company earned $2.69 per share in the second quarter, below analysts' estimates of $2.83.

Air Products also recorded a charge of $2.3 billion in the reported quarter due to costs related to its exit from three projects in the U.S.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
5PM Hourly update
5PM Hourly update
Oct 21, 2025
Please add/update the following to the Reuters Daybook for Wednesday, October 22: UPDATES WITH ROOM CHANGE SENATE ENVIRONMENT AND PUBLIC WORKS -- 10 a.m. -- Holds a hearing on the nominations of: Mitch Graves, Jeff Hagood, Randall Jones, and Arthur Graham to be members of the Board of Directors at the Tennessee Valley Authority ( TVC ) . The nominees...
Sagicor Financial Company Receives Ratings Upgrade from Fitch
Sagicor Financial Company Receives Ratings Upgrade from Fitch
Oct 21, 2025
05:20 PM EDT, 10/21/2025 (MT Newswires) -- Sagicor Financial ( SGCFF ) on Tuesday said global credit-rating agency Fitch Ratings upgraded its Long-Term Issuer Default Rating to BBB from BBB- and its senior unsecured debt rating to BBB- from BB+, while stating the outlook remains Stable. The company said Fitch cited Sagicor's strengthened core profitability, the second year of consolidated...
National Bank Q3 Earnings, Revenue Rise
National Bank Q3 Earnings, Revenue Rise
Oct 21, 2025
05:44 PM EDT, 10/21/2025 (MT Newswires) -- National Bank ( NBHC ) reported adjusted Q3 earnings late Tuesday of $0.96 per diluted share, up from $0.86 a year earlier. Analysts polled by FactSet expected $0.85. Revenue, expressed as the sum of net interest income and total noninterest income, for the quarter ended Sep. 30 was $108.9 million, up from $106.0...
Alector's Latozinemab Fails in Phase 3 Dementia Trial; Workforce Cut by 49%; Shares Fall After Hours
Alector's Latozinemab Fails in Phase 3 Dementia Trial; Workforce Cut by 49%; Shares Fall After Hours
Oct 21, 2025
05:44 PM EDT, 10/21/2025 (MT Newswires) -- Alector ( ALEC ) said Tuesday that its Phase 3 trial of latozinemab in frontotemporal dementia caused by a progranulin gene mutation failed to meet its primary clinical endpoint. The company will halt the continuation study for latozinemab and reduce its workforce by 49%. Sara Kenkare-Mitra, president and head of research and development,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved